[HTML][HTML] α-Synuclein misfolding and Parkinson's disease
Substantial evidence links α-synuclein, a small highly conserved presynaptic protein with
unknown function, to both familial and sporadic Parkinson's disease (PD). α-Synuclein has …
unknown function, to both familial and sporadic Parkinson's disease (PD). α-Synuclein has …
Intrinsically disordered protein
Proteins can exist in a trinity of structures: the ordered state, the molten globule, and the
random coil. The five following examples suggest that native protein structure can …
random coil. The five following examples suggest that native protein structure can …
[HTML][HTML] Entrapment of curcumin in soy protein isolate using the pH-driven method: Nanoencapsulation and formation mechanism
H Li, X Zhang, C Zhao, H Zhang, Y Chi, L Wang… - Lwt, 2022 - Elsevier
The use of curcumin in the food industry is constrained by its poor aqueous dispersibility and
instability. Previous studies have shown that stable curcumin nanoparticles can be prepared …
instability. Previous studies have shown that stable curcumin nanoparticles can be prepared …
Lyophilization and development of solid protein pharmaceuticals
W Wang - International journal of pharmaceutics, 2000 - Elsevier
Developing recombinant protein pharmaceuticals has proved to be very challenging
because of both the complexity of protein production and purification, and the limited …
because of both the complexity of protein production and purification, and the limited …
Extrinsic fluorescent dyes as tools for protein characterization
A Hawe, M Sutter, W Jiskoot - Pharmaceutical research, 2008 - Springer
Noncovalent, extrinsic fluorescent dyes are applied in various fields of protein analysis, eg to
characterize folding intermediates, measure surface hydrophobicity, and detect aggregation …
characterize folding intermediates, measure surface hydrophobicity, and detect aggregation …
Instability, stabilization, and formulation of liquid protein pharmaceuticals
W Wang - International journal of pharmaceutics, 1999 - Elsevier
One of the most challenging tasks in the development of protein pharmaceuticals is to deal
with physical and chemical instabilities of proteins. Protein instability is one of the major …
with physical and chemical instabilities of proteins. Protein instability is one of the major …
Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe
GV Semisotnov, NA Rodionova… - Biopolymers …, 1991 - Wiley Online Library
Binding of the hydrophobia fluorescent probe, 1‐anilino‐naphthalene‐8‐sulfonate (ANS), to
synthetic polypeptides and proteins with a different structural organization has been studied …
synthetic polypeptides and proteins with a different structural organization has been studied …
Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein: a possible molecular link between Parkinson′ s disease and heavy …
VN Uversky, J Li, AL Fink - Journal of Biological Chemistry, 2001 - ASBMB
Parkinson's disease involves the aggregation of α-synuclein to form fibrils, which are the
major constituent of intracellular protein inclusions (Lewy bodies and Lewy neurites) in …
major constituent of intracellular protein inclusions (Lewy bodies and Lewy neurites) in …
Structural and emulsifying properties of soy protein isolate subjected to acid and alkaline pH-shifting processes
Structural unfolding of soy protein isolate (SPI) as induced by holding (0, 0.5, 1, 2, and 4 h)
in acidic (pH 1.5− 3.5) and alkaline (pH 10.0− 12.0) pH solutions, followed by refolding (1 h) …
in acidic (pH 1.5− 3.5) and alkaline (pH 10.0− 12.0) pH solutions, followed by refolding (1 h) …
Effects of glycosylation on the stability of protein pharmaceuticals
RJ Solá, KAI Griebenow - Journal of pharmaceutical sciences, 2009 - Elsevier
In recent decades, protein-based therapeutics have substantially expanded the field of
molecular pharmacology due to their outstanding potential for the treatment of disease …
molecular pharmacology due to their outstanding potential for the treatment of disease …